Navigation Links
Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair
Date:2/25/2009

ructure necessary for optimal healing. A silk-based scaffold that supports immediate tissue infiltration and maintains its integrity over a longer term, as it is being bioresorbed by the body, may be significant in addressing these clinical needs."

"First and foremost, it is our sincere hope that the properties of the SeriScaffold technology could represent a significant shift in soft tissue repair, in terms of the surgical outcome and healing process, for patients," added Altman.

"We plan to leverage the well known physical properties of silk in additional surgical applications, and will be initiating new clinical studies using our novel technology. Our goal is to develop a portfolio of tailored scaffold products, to be available in a multitude of contoured shapes and sizes, for those patients undergoing breast reconstruction and/or augmentation," said Altman. "It is our intent that our product portfolio serve the unique needs of this patient population where a significant loss of tissue occurs during surgery, with the hope of better restoring the repair site to a more natural state."

The SeriScaffold(TM) platform technology provides a unique natural protein-based alternative to synthetic materials and graft products harvested from human or animal cadaver tissue. "We believe our proprietary SeriScaffold technology has applications for a wide range of necessary procedures for patients requiring reconstructive plastic surgery, as well as for patients undergoing elective and other forms of soft tissue repair surgery," said Altman.

With additional research and development planned, SeriScaffold technology-based products have the potential to be lead products in the plastic surgery market, where 860,000 aesthetic augmentation and reconstructive surgical procedures are conducted annually. This silk-based scaffold technology is also showing promise in other procedures includin
'/>"/>

SOURCE Serica Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
2. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
3. ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
4. BioNanomatrixs Revolutionary Whole Genome Analysis Platform Named to MIT Technology Reviews Annual 10 Emerging Technologies List
5. Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
6. Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
7. Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial Results
8. Palatin Technologies to Report Fiscal Year 2009 Second Quarter Results; Conference Call and Webcast on February 17, 2009
9. OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China
10. Cumberland Emerging Technologies and UT Research Foundation Sign License Agreement for New Technology
11. Celsis In Vitro Technologies and Promega to Offer Fast, Reliable Solutions for ADME-Tox Testing With Primary Hepatocytes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Ipsen ... IPN; ADR: IPSEY), today announced that ... to as Somatuline®) was approved by the U.S. ... of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients ... or metastatic disease to improve progression-free survival (PFS). ...
(Date:12/17/2014)... Xeno Diagnostics has again received an ... COLA inspection. Xeno has met all criteria for ... organization. Accreditation is earned only by laboratories that ... demonstrate continued accuracy in the performance of proficiency ... , While the Laboratory Excellence award ...
(Date:12/17/2014)... Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... disease, today announced the next step in its expanded ... solutions provider with the naming of current Chief Operating ... Executive Officer, while current Chairman of the Board and ... as Chairman. These changes are effective January 1, 2015. ...
(Date:12/17/2014)... 17, 2014 Tigercat Pharma, Inc. today ... evaluating the investigational oral NK-1 receptor antagonist VPD-737 ... chronic itch who are unresponsive or inadequately responsive ... steroids and antihistamines. The primary ... Scale (VAS) itch score from baseline, comparing drug ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
... Fla., Oct. 30 Pasteuria Bioscience, Inc., (http://www.pasteuriabio.com ... for agriculture,s largest unmet pest problem, announced,today that ... the new Chief,Executive Officer. Dr. Duncan has also ... succeeds Dr. Kelly Smith who will remain active ...
... NEW YORK and MONTREAL, Oct. 30 /PRNewswire-FirstCall/ - ... 30% interest in,Bacteria Bank Ltd. Bacteria Bank ... over ten,thousand cryogenically stored bacteria for use in ... headed by Dr. Karl Weiss a world,renowned bacteriologist. ...
... SAN DIEGO, Oct. 30 CryoCor, Inc. (Nasdaq:,CRYO), ... of cardiac,arrhythmias, announced today that Edward F. Brennan, ... Chief Financial Officer, are,scheduled to present at the ... York, NY on Tuesday, November 6, 2007 at ...
Cached Biology Technology:Pasteuria Bioscience Taps New CEO David N. Duncan 2Pasteuria Bioscience Taps New CEO David N. Duncan 3ICBS acquires 30% interest in Bacteria Bank Ltd. 2CryoCor to Present at CIBC World Markets 18th Annual Healthcare Conference 2
(Date:12/10/2014)... , Dec. 08, 2014 Research and ... the addition of the "Biometrics Market in ... http://photos.prnewswire.com/prnh/20130307/600769 ... projects such as rural banking and upgradation of ... trends witnessed in the market. Besides the aforementioned ...
(Date:12/3/2014)... 2014   Marvin Test Solutions , a ... for military, aerospace, and manufacturing organizations, today announced ... TS-900 PXI semiconductor test platform . The ... systems to customers at a fraction of the ... ATE. "Our semiconductor customers asked ...
(Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, ... the Internet of Things (IoT), today announced the appointment ... chief operating officer. Previously a strategic advisor to the ... and operations. Mr. Traynor is based out of the ... He reports to Chris Muench , Chief Executive ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2
... the most important paradigms of contemporary society, given the large ... and finally thrown way, this type of waste not being ... working in the recycling sector will be able to save ... new system developed by Tecnalia Research & Innovation. This ...
... COPENHAGEN, DENMARKNatural products marketed as plant growth enhancers ... typically produced by small companies with limited research ... nor have claims about product effectiveness been documented ... Copenhagen investigated the growth regulatory effect of Tea ...
... from Bishop Museum, Honolulu has found the world,s ... world,s smallest tetrapods (non-fish vertebrates). The frogs belong to the genus ... adults of the two new species - named Paedophryne dekot ... length. The study was published in the open access journal ...
Cached Biology News:1,200 recycling sector companies will save up to 10 percent thanks to a new system developed by Tecnalia 2Plant growth affected by tea seed powder 2World's smallest frogs discovered in New Guinea 2
... Shimadzu Biotech presents PsiPort Mass Directed ... review and data acquisition system designed ... for the life science and pharmaceutical ... designed specifically to simplify high throughput ...
... Anti-M13 polyclonal antibody was derived from rabbit ... particles.Recombinant protein domains such as antibody fragments ... pIII and displayed on phage using phagemid-based ... utilized in the Ph.D. libraries. Anti-M13 pIII ...
... The Rapid DNA Ligation Kit ... blunt-end DNA fragments in just ... Depending on the DNA ... concentration) or concatemeric (high DNA ...
... catalyzes the transfer of the ... 5-terminus of polynucleotides or to ... The enzyme, purified from recombinant ... to phosphorylate RNA, DNA and ...
Biology Products: